Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Electron. j. biotechnol ; 15(1): 3-3, Jan. 2012. ilus, tab
Article in English | LILACS | ID: lil-640529

ABSTRACT

The biodegradation kinetics of o-cresol was examined by acclimatized P. putida DSM 548 (pJP4) in batch experiments at varying initial o-cresol concentrations (from 50 to 500 mg/L). The kinetic parameters of o-cresol aerobic biodegradation were estimated by using the Haldane substrate inhibition equation. The biodegradation kinetics of o-cresol was investigated. In batch culture reactors, the Maximum specific growth rate (μmax), Monod constant (Ks) and the inhibition constant (Ki) were established as 0.519 h-1, 223.84 mg/L and 130.883 mg/L, respectively. o-cresol biodegradation in a batch-recirculation bioreactor system by immobilized P. putida was also studied. The recycled packed bed reactor system, which was composed of Ca-alginate beads and pumice on which cells immobilized, has been performed to determine possible stability for further developments.


Subject(s)
Biodegradation, Environmental , Cresols/metabolism , Pseudomonas putida/chemistry , Bioreactors , Cells, Immobilized , Phenols/metabolism , Kinetics
2.
Mem. Inst. Oswaldo Cruz ; 104(5): 678-682, Aug. 2009. ilus, tab
Article in English | LILACS | ID: lil-528072

ABSTRACT

Bacteria isolated from marine sponges found off the coast of Rio de Janeiro, Brazil, were screened for the production of antimicrobial substances. We report a new Pseudomonas putida strain (designated P. putida Mm3) isolated from the sponge Mycale microsigmatosa that produces a powerful antimicrobial substance active against multidrug-resistant bacteria. P. putida Mm3 was identified on the basis of 16S rRNA gene sequencing and phenotypic tests. Molecular typing for Mm3 was performed by RAPD-PCR and comparison of the results to other Pseudomonas strains. Our results contribute to the search for new antimicrobial agents, an important strategy for developing alternative therapies to treat infections caused by multidrug-resistant bacteria.


Subject(s)
Animals , Anti-Bacterial Agents/pharmacology , Drug Resistance, Multiple, Bacterial/drug effects , Gram-Negative Bacteria/drug effects , Gram-Positive Bacteria/drug effects , Porifera/microbiology , Pseudomonas putida/chemistry , Anti-Bacterial Agents/biosynthesis , Anti-Bacterial Agents/isolation & purification , Microbial Sensitivity Tests , Oceans and Seas , Phylogeny , Pseudomonas putida/genetics , Pseudomonas putida/isolation & purification , Random Amplified Polymorphic DNA Technique , RNA, Bacterial/genetics , /genetics
SELECTION OF CITATIONS
SEARCH DETAIL